In this study, we identified MG53 as a novel regulator of RAC1 and verified that MG53 exerted its anti-tumor effect by directly interacting with RAC1 and inducing the ubiquitination-mediated degradation of RAC1 in HCC. The gene discussed is TRIM72; the disease is neoplasm.